1. Mutations in the gene encoding the al -subunit of the skeletal muscle dihydropyridine (DHP) receptor are responsible for familial hypokalaemic periodic paralysis (HypoPP), an autosomal dominant muscle disease. We investigated myotubes cultured from muscle of patients with arginine-to-histidine substitutions in putative voltage sensors, IIS4 (R528H) and IVS4 (R1239H), of the DHP receptor al -subunit. 2. Analysis of the messenger ribonucleic acid (mRNA) in the myotubes from such patients indicated transcription from both the normal and mutant genes. 3. In control myotubes, the existence of the slow L-type current and of two rapidly activating and inactivating calcium current components (T-type with a maximum at about -20 mV and 'third type' with a maximum at +10 to +20 mV) was confirmed. In the myotubes from patients with either mutation, the third-type current component was seen more frequently and, on average, with larger amplitude. 4. In myotubes with the IVS4 mutation (R1239H) the maximum L-type current density was smaller than control (-0'53 + 0-31 vs. -1i41 + 0-71 pA pF-1). The voltage dependence of activation was normal, and hyperpolarizing prepulses to -120 mV for 20 s did not increase the reduced current amplitude during test pulses. 5. In myotubes with the IIS4 mutation (R528H) the L-type current-voltage relation, determined at a holding potential of -90 mV, was normal. However, the voltage dependence of inactivation was shifted by about 40 mV to more negative potentials (voltage at half-maximum inactivation, V% = -41X5 + 8X2 vs. -4X9 + 4X3 mV in normal controls). 6. We conclude that the arginine-to-histidine exchanges enhance inactivation of the L-type calcium channel and do not alter its voltage-dependent activation.
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The transverse tubular membrane of skeletal muscle contains the putative voltage-sensing structures, contains high density dihydropyridine receptor proteins receptors for calcium channel-modulating drugs, as well as (DHP receptors) which are thought to function both as the calcium-conducting pore (Catterall & Striessnig, 1992) . voltage-dependent calcium channels and as voltage The understanding of the structure-function relations for sensors for the control of calcium release from the this polypeptide has been much advanced by studies of sarcoplasmic reticulum (see Rios & Pizarro, 1991) . The the mouse mutant mdg (muscular dysgenesis) which does protein consists of five subunits: al, a2/4, ft and y not express the alx -subunit (Tanabe, Mikami, Niidome, (Hofmann, Biel & Flockerzi, 1994) . The aci -subunit Numa, Adams & Beam, 1993) . Muscle cells which are § To whom correspondence should be addressed.
This manuscript was accepted as a Short Paper for rapid publication. B homozygous for the mdg mutation lack both DHPsensitive inward current and excitation-contraction coupling (Tanabe, Beam, Powell & Numa, 1988 (Iaizzo, Quasthoff & Lehmann-Horn, 1994) . Genetic linkage and mutation data have been presented for family 8 (family B in Fontaine et al. 1994 and Jurkat-Rott et al. 1994) and families 11, 16, 19 and 20 (Jurkat-Rott et al. 1994 (Vt, 8, ) to +20 mV (see Fig. 3 ). The voltage dependence of steadystate inactivation of the fast activating and inactivating third-type current (for definition see below) was determined by applying 1 s prepulses to potentials between -80 and 0 mV followed by a 100 ms test pulse to +10 mV (without any intermediate repolarization).
The bathing solution contained (mM): TEA-Cl, 120; CaCl2, 10;
MgCl2, 1; Hepes, 10; glucose, 5; TTX, 0-02; EGTA, 0-1; pH 7-4 (adjusted with TEA-OH). The patch pipettes were filled with (mM): CsCl, 130; MgCl2, 0 5; Hepes, 10; EGTA, 1; Mg-ATP, 5; phosphocreatine, 5; pH 7-2 (adjusted with CsOH). All measurements were performed at room temperature. In some experiments, the dihydropyridine drug nifedipine was added from a 10 mm stock solution in dimethyl sulphoxide (DMSO) to obtain a final concentration of 5/SM. Nifedipine was photolysed using intense light flashes of about 1 ms duration generated by a Xenon arc lamp (JML; G. Rapp, Dossenheim, Germany) and filtered with an UG1 1 (Schott) filter (see Feldmeyer, Melzer, Pohl & Z6llner, 1992 Fig. 1A . Examples of the cosegregation of the mutations with the disease are given in Fig. lB . Either mutation was also found (in addition to the normal sequence) in the RNA isolated from myotubes derived from the muscle specimens of three of the patients (examples in Fig. 1 C) (V%) of the L-type current was -4-9 + 4.3 mV (Fig. 3A) .
(ii) The T-type current, detected in addition to the L-type current in the remaining 57 % of the cells, was characterized by a voltage threshold of about -50 mV and reached a maximum of -0-43 + 0-68 pA pF-1 at -20 mV ( Fig. 2A) . (iii) In 34 % of the total number of cells, a second type of fast calcium inward current ('third type' according to Rivet et al. 1992 ) was recorded which revealed kinetics similar to the T-type. Its maximum appeared at -20 mV, i.e. 30 mV more positive than the maximum of the T-type current. Since this current was found only in a third of the cells with generally small amplitude, it did not lead to a distinct peak in the average current-voltage relation of the fast currents ( Fig. 2A) . It could, however, be more easily detected in the patients' myotubes ( Fig. 2B and C) . V% of the third-type current was -45 0 + 4X8 mV (Fig. 3A) , about 10 mV more positive than reported by Rivet et al. (1992 myotubes of the patient with the R528H mutation (family 19) was not different from controls (Fig. 2B) (Fig. 2B) .
Whereas the inactivation curve of the third type was not different from controls, the inactivation curve of the L-type current was markedly shifted to more negative potentials (Fig. 3B) (n = 47). B, mutation R528H (n = 15). C, mutation Rl1239H (n = 28). The density of the DHP-sensitive L-type current is significantly reduced in the 0 to +50 mV range for the RI1239H mutation (Student's paired t test, P= 0-02) while it is unaltered in R528H. The amplitudes of the third-type current are increased for both mutations. The differences between controls and HypoPP are statistically significant in the +10 to +30 mV range (P = 0-02). homogeneous population of channels with abnormal inactivation. It might be explained by an oligomeric arrangement of the ion-conducting channels forming a functional unit in which one mutant monomer is sufficient to produce malfunction of the entire complex. Such a functional unit might be constituted by the transverse tubular tetrads (Block, Imagawa, Campbell & FranziniArmstrong, 1988; Lamb, 1992) . Calcium currents in myotubes with the R1239H mutation In the myotubes derived from three related patients (family 8), the peak density of the L-type current was reduced to about one-third of the control values, i.e. -0 53 + 0-31 pA pF-1 at +20 mV (Fig. 2C) . The reduction of the average current density was statistically significant in the 0 to +50 mV range (P = 0 02). Similar to the finding for R528H myotubes, the fraction of cells showing the third-type current was increased from 34 to 75 % leading to a pronounced second phase of the current-voltage relation with a peak value of -0 74 + 0-72 pA pF-' at +10 mV (Fig. 2C) . The inactivation curve of the third-type current showed no significant deviation from the control (data see legend of Fig. 3C ). Since strongly reduced amplitudes made the determination of the inactivation curve of the L-type current difficult, the measurements were performed on selected myotubes with larger amplitudes. The inactivation curve obtained from these myotubes revealed a normal V% value (-4-5 + 2-9 mV) when fitted with a single Boltzmann function (Fig. 3C) . The least-squares fit of the inactivation curve deviated from the data points due to a region of reduced slope between -50 and -20 mV. This deviation might result from the contribution of a channel population with a left-shifted inactivation curve as seen in the R528H mutation (Fig. 3B) . To test whether the reduced current density results from partial inactivation at the holding potential of -90 mV, we applied strong hyperpolarizing prepulses to -120 mV for 20 s. This procedure did not lead to an increase in the L-type current; thus, the reduction of the current density seems to be voltage independent. It seems possible that the channels carrying the IVS4 mutation are completely nonfunctional or permanently inactivated so that the reduced current density results from the normal channels only. Functional implications of the DHP receptor mutations Presence of messenger ribonucleic acid (mRNA) of both normal and mutant DHP receptors and clear deviations from the normal calcium current pattern in these myotubes, suggest the expression of modified channels in the membrane. It seems unlikely that the enhanced third-type current reflects mutant L-type calcium channels, because this current can also be found in control myotubes. Its increased average amplitude may be due to a delay in the normal downregulation of the corresponding channel. On the other hand, it is likely that the changes observed in the L-type current are direct consequences of the mutations in the al-subunit. As this current is the main calcium current component of adult skeletal muscle fibres, the myotubes of patients can be regarded as a valuable model for the elucidation of the pathogenesis of hypokalaemic periodic paralysis. The mutations reduce the positive charge in regions supposedly involved in voltage sensing. Our results point to an enhanced inactivation rather than an effect on voltage-dependent activation of the L-type current. Parallels to results on analogous R1448H/C mutations of the sodium channel a-subunit causing paramyotonia congenita by modifying inactivation (Chahine et al. 1994) can be noted. These mutations do not affect channel activation although they are also located in the IVS4 putative voltage sensor region. How inactivation of the L-type calcium current is related to hypokalaemia-induced attacks of muscle weakness which characterize familial hypokalaemic periodic paralysis can so far only be speculated upon. The DHP receptor has been proposed to act as a calcium channel and as a control device for internal calcium release (Rios & Pizarro, 1991) ; therefore, both functions may be affected. Reduced calcium release is equivalent to muscle weakness. The hypokalaemia-induced membrane depolarization observed in excised muscle fibres (Riidel et al. 1984) (Schnier, Liittgau & Melzer, 1993) similar to the R528H mutation. However, small changes in monovalent cations like potassium should not cause a significant shift of the inactivation curve as long as calcium is present in millimolar concentrations. Therefore, only a major change in ion selectivity of the cation binding site would explain the high potassium sensitivity in HypoPP. Further research is required to test selectivity of the cation binding site of the mutant DHP receptors. Measurements of both calcium currents and calcium transients will be necessary in order to find out whether both functions of the DHP receptor are modified in an analogous way. We expect that continuing work on hypokalaemic periodic paralysis will clarify the function of the L-type current in skeletal muscle and refine the model for excitation-contraction coupling.
